{"brief_title": "A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer", "brief_summary": "The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine in patients with pancreatic cancer.", "condition": ["Pancreatic Cancer"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["Gemcitabine", "LY293111", "placebo"], "criteria": "Inclusion Criteria: - Adenocarcinoma of the pancreas that is locally advanced or metastatic and not amenable to resection with curative intent - Tumor that can be measured by x-ray or scan - Adequate organ function Exclusion Criteria: - Inability to swallow capsules - Documented brain metastases - Prior chemotherapy or biological therapy for this disease", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Pancreatic Neoplasms", "Gemcitabine"], "id": "NCT00055250"}